Cencora vs Doximity

Side-by-side comparison of AI visibility scores, market position, and capabilities

Doximity leads in AI visibility (86 vs 77)
Cencora logo

Cencora

LeaderHealthcare Tech

Enterprise

Conshohocken PA pharmaceutical distribution (NYSE: COR, formerly AmerisourceBergen) at $316B+ revenue; Retina Consultants of America acquisition $4.4B (Jan 2025) expanding into specialty physician care competing with McKesson.

AI VisibilityBeta
Overall Score
B77
Category Rank
#44 of 596
AI Consensus
88%
Trend
stable
Per Platform
ChatGPT
75
Perplexity
74
Gemini
76

About

Cencora, Inc. (formerly AmerisourceBergen, rebranded August 2023) is a Conshohocken, Pennsylvania-based pharmaceutical distribution and healthcare services company — publicly traded on the New York Stock Exchange (NYSE: COR) as an S&P 500 Health Care component, ranked #10 on the 2024 Fortune 500 and #24 on the Global Fortune 500 — distributing brand-name, generic, and specialty pharmaceuticals, over-the-counter products, and home healthcare supplies to 110,000+ points of care across 11 countries through 46,000+ employees and $316+ billion in annual revenue. Cencora operates as one of the "Big Three" pharmaceutical wholesalers in the United States alongside McKesson and Cardinal Health, collectively supplying approximately 90%+ of the US pharmaceutical supply chain. The company distributes from 26 US pharmaceutical distribution centers and 1,300+ locations across 50+ countries. In January 2025, Cencora completed the acquisition of approximately 85% interest in Retina Consultants of America (RCA) — a leading management services organization for retina specialists — for $4.4 billion, advancing its strategy to expand from pharmaceutical distribution into specialty physician-administered treatments and the high-growth specialty pharmaceutical services market. Founded through the 2001 merger of AmeriSource Health Corporation and Bergen Brunswig Corporation, with predecessor companies tracing to the 1970s, Cencora adopted its current name (meaning "center, core, heart" in multiple languages) in 2023 to signal the brand's evolution beyond commodity distribution.

Full profile
Doximity logo

Doximity

GrowthHealthTech

Physician Professional Network

Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.

AI VisibilityBeta
Overall Score
A86
Category Rank
#6 of 596
AI Consensus
85%
Trend
stable
Per Platform
ChatGPT
85
Perplexity
84
Gemini
88

About

Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.

Full profile

AI Visibility Head-to-Head

77
Overall Score
86
#44
Category Rank
#6
88
AI Consensus
85
stable
Trend
stable
75
ChatGPT
85
74
Perplexity
84
76
Gemini
88
75
Claude
81
79
Grok
85

Key Details

Category
Enterprise
Physician Professional Network
Tier
Leader
Growth
Entity Type
company
brand

Capabilities & Ecosystem

Capabilities

Only Doximity
Physician Professional Network

Integrations

Only Cencora
Cencora is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.